High Levels of Circulating Spike Protein Found in Myocarditis Patients Who Took mRNA COVID-19 Vaccine: Study

High Levels of Circulating Spike Protein Found in Myocarditis Patients Who Took mRNA COVID-19 Vaccine: Study
3D print of a spike protein on the surface of SARS-CoV-2. Spike proteins cover the surface of SARS-CoV-2 and enable the virus to enter and infect human cells. NIH
Updated:
0:00

People who suffered from myocarditis after receiving an mRNA-based COVID-19 vaccine were found to have persistently higher levels of circulating spike protein compared to those who also received an mRNA-based COVID-19 vaccine but did not develop myocarditis, according to findings from a new study.

The study, published Jan. 4 in the Journal of the American Heart Association, sought to understand better the immune profiles—also referred to as immunoprofiles—of people who suffered from myocarditis after receiving an mRNA-based vaccine.